AC
GH icon

Avestar Capital’s Guardant Health GH Stock Holding History

Avestar Capital’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,804
Closed -$318K – 335
2022
Q1 		$318K Sell
4,804
-731
-13% -$50K 0.05% 296
2021
Q4 		$554K Buy
5,535
+216
+4% +$22.3K 0.07% 241
2021
Q3 		$665K Buy
5,319
+535
+11% +$63.6K 0.09% 241
2021
Q2 		$594K Buy
4,784
+252
+6% +$33.9K 0.08% 247
2021
Q1 		$745K Buy
4,532
+1,508
+50% +$228K 0.17% 127
2020
Q4 		$390K Buy
3,024
+703
+30% +$80.9K 0.11% 174
2020
Q3 		$239K Buy
+2,321
New +$212K 0.08% 190

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Avestar Capital's GH Position: Q2 2022 in Review

Avestar Capital sold out of Guardant Health (GH) in Q2 2022, closing a stake of 4,804 shares — an estimated $318K sold.

Avestar Capital first reported a position in GH in Q3 2020 and held it in 7 quarters. The position peaked at $745K in Q1 2021. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

  • Avestar Capital reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
  • Avestar Capital sold 4,804 Guardant Health shares in Q2 2022, an estimated $318K.
  • Avestar Capital first reported a position in Guardant Health in Q3 2020 and held it in 7 quarters.
  • Avestar Capital's Guardant Health position peaked at $745K in Q1 2021.
  • 332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on Avestar Capital's 13F filing for Q2 2022, filed 28 Jul 2022.